Do Symptoms and Serum Calcium Levels Affect the Results of Surgical Treatment of Primary Hyperparathyroidism?

Table 4

Comparison of preoperative data between SPHPT group and ASPHPT group.

Index	SPHPT group; n=89	ASPHPT group; n=108	P value
Age (y) ± SD	47.93 ± 12.29	49.54 ± 12.33	0.394
Sex			0.262
male	26 (29.21%)	24 (22.22%)
female	63 (70.79%)	84 (77.78%)
Preoperative PTH (uIU/ml) ± SD	1110.69 ± 1058.09	435.98 ± 396.14	< 0.0001
Preoperative AKP (U/L) ± SD	353.67 ± 418.62	190.25 ± 201.31	< 0.0001
Preoperative Ca (mmol/L) ± SD	3.12 ± 0.51	2.80 ± 0.38	< 0.0001
Preoperative P (mmol/L) ± SD	0.94 ± 0.42	0.96 ± 0.32	0.702
Symptom type I
Single symptoms	57.30%(51/89)	-
Multiple symptoms	42.70%(38/89)	-
Symptom type II
nephrolithiasis	48.31%(43/89)	-
osseous lesion	50.56%(45/89)	-
gastrointestinal symptoms	17.98%(16/89)	-
others	29.21%(26/89)	-

Abbreviations: SPHPT, symptomatic primary hyperparathyroidism; ASPHPT, asymptomatic primary hyperparathyroidism; PTH, parathyroid hormone; AKP, alkaline phosphatase.